• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国炎症性肠病住院率的趋势。

Trends in hospitalization rates for inflammatory bowel disease in the United States.

作者信息

Bewtra Meenakshi, Su Chinyu, Lewis James D

机构信息

Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

出版信息

Clin Gastroenterol Hepatol. 2007 May;5(5):597-601. doi: 10.1016/j.cgh.2007.01.015. Epub 2007 Mar 26.

DOI:10.1016/j.cgh.2007.01.015
PMID:17382602
Abstract

BACKGROUND & AIMS: This study examined trends in hospitalization and surgery rates for inflammatory bowel disease (IBD) in the United States over a 14-year period.

METHODS

We performed an analysis of secular trends of hospitalization and surgery rates from Crohn's disease (CD) and ulcerative colitis (UC) using the 1990 to 2003 National Hospital Discharge Survey data. The Spearman correlation coefficient was used to examine the association between calendar year and rates of hospitalization or bowel resection surgery.

RESULTS

From 1990 to 2003, the hospitalization rates for patients with a primary diagnosis of IBD per 100,000 people ranged from 9.3 to 17.1 for CD and 8.2 to 12.4 for UC, with a significant trend for increasing hospitalization rates for CD (rho = .83, P = .0002) but not UC (rho = .06, P = .83). The annual rates of bowel resection surgeries per 100,000 people ranged from 2.8 to 5.0 for CD and from 1.6 to 3.4 for UC, with no significant trend for CD (rho = .30, P = .30) or UC (rho = -.31, P = .28). As expected, there was a significant trend for shorter hospitalizations for both CD (rho = -.98, P < .0001) and UC (rho = -.87, P < .0001). However, total hospital days did not change significantly for either CD or UC.

CONCLUSIONS

Despite advances in therapy, IBD hospitalization and surgery rates in the United States have not decreased since 1990. Rather, there has been a significant increase in hospitalizations for CD, with stable rates of bowel resection surgery for CD and hospitalization and surgery for UC.

摘要

背景与目的

本研究调查了14年间美国炎症性肠病(IBD)的住院率和手术率趋势。

方法

我们利用1990年至2003年全国医院出院调查数据,对克罗恩病(CD)和溃疡性结肠炎(UC)的住院率和手术率的长期趋势进行了分析。采用Spearman相关系数检验日历年与住院率或肠切除手术率之间的关联。

结果

1990年至2003年,以IBD为主要诊断的患者每10万人的住院率,CD为9.3至17.1,UC为8.2至12.4。CD的住院率有显著上升趋势(rho = 0.83,P = 0.0002),而UC没有(rho = 0.06,P = 0.83)。每10万人的年度肠切除手术率,CD为2.8至5.0,UC为1.6至3.4。CD(rho = 0.30,P = 0.30)或UC(rho = -0.31,P = 0.28)均无显著趋势。正如预期的那样,CD(rho = -0.98,P < 0.0001)和UC(rho = -0.87,P < 0.0001)的住院时间均有显著缩短趋势。然而,CD和UC的总住院天数均无显著变化。

结论

尽管治疗取得了进展,但自1990年以来,美国IBD的住院率和手术率并未下降。相反,CD的住院率显著上升,CD的肠切除手术率以及UC的住院率和手术率保持稳定。

相似文献

1
Trends in hospitalization rates for inflammatory bowel disease in the United States.美国炎症性肠病住院率的趋势。
Clin Gastroenterol Hepatol. 2007 May;5(5):597-601. doi: 10.1016/j.cgh.2007.01.015. Epub 2007 Mar 26.
2
Hospitalization, surgery, and readmission rates of IBD in Canada: a population-based study.加拿大炎症性肠病的住院率、手术率和再入院率:一项基于人群的研究。
Am J Gastroenterol. 2006 Jan;101(1):110-8. doi: 10.1111/j.1572-0241.2006.00330.x.
3
A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients.一项关于住院炎症性肠病患者艰难梭菌感染的患病率及影响的全国性调查。
Am J Gastroenterol. 2008 Jun;103(6):1443-50. doi: 10.1111/j.1572-0241.2007.01780.x. Epub 2008 May 29.
4
Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database.2003 - 2005年哥本哈根市及郡炎症性肠病发病率上升与手术率下降:一项基于丹麦克罗恩病和结肠炎数据库的人群研究
Am J Gastroenterol. 2006 Jun;101(6):1274-82. doi: 10.1111/j.1572-0241.2006.00552.x.
5
Rising hospitalization rates for inflammatory bowel disease in the United States between 1998 and 2004.1998年至2004年间,美国炎症性肠病的住院率不断上升。
Inflamm Bowel Dis. 2007 Dec;13(12):1529-35. doi: 10.1002/ibd.20250.
6
Hospitalization for inflammatory bowel disease in the United States between 1970 and 2004.1970年至2004年间美国炎症性肠病的住院情况。
J Clin Gastroenterol. 2009 Apr;43(4):297-300. doi: 10.1097/MCG.0b013e31816244a0.
7
Nationwide temporal trends in incidence of hospitalization and surgical intestinal resection in pediatric inflammatory bowel diseases in the United States from 1997 to 2009.1997 年至 2009 年美国儿童炎症性肠病住院和手术肠道切除的全国时间趋势。
Inflamm Bowel Dis. 2013 Oct;19(11):2423-32. doi: 10.1097/MIB.0b013e3182a56148.
8
Early azathioprine/biological therapy is associated with decreased risk for first surgery and delays time to surgery but not reoperation in both smokers and nonsmokers with Crohn's disease, while smoking decreases the risk of colectomy in ulcerative colitis.早期使用硫唑嘌呤/生物制剂治疗与克罗恩病患者(无论是否吸烟)首次手术风险降低和手术时间延迟有关,但不增加再次手术风险,而吸烟则降低溃疡性结肠炎患者结肠切除术的风险。
Eur J Gastroenterol Hepatol. 2010 Jul;22(7):872-9. doi: 10.1097/MEG.0b013e32833036d9.
9
Time trends in therapies and outcomes for adult inflammatory bowel disease, Northern California, 1998-2005.1998 - 2005年北加利福尼亚成人炎症性肠病治疗方法及治疗结果的时间趋势
Gastroenterology. 2009 Aug;137(2):502-11. doi: 10.1053/j.gastro.2009.04.063. Epub 2009 May 13.
10
Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease.诊断时的表型及其他潜在预后因素对炎症性肠病病程的影响。
Am J Gastroenterol. 2009 Feb;104(2):371-83. doi: 10.1038/ajg.2008.38. Epub 2009 Jan 27.

引用本文的文献

1
Cirsimaritin Alleviates Dextran Sodium Sulfate-Induced Acute Colitis in Experimental Animals: A Therapeutic Approach for Inflammatory Bowel Disease.Cirsimaritin减轻实验动物中葡聚糖硫酸钠诱导的急性结肠炎:一种炎症性肠病的治疗方法。
Prev Nutr Food Sci. 2024 Mar 31;29(1):31-39. doi: 10.3746/pnf.2024.29.1.31.
2
Hospital Cost of Inflammatory Bowel Disease and Its Determinants in a Multicenter Study From Iran.伊朗一项多中心研究中炎症性肠病的医院成本及其决定因素
Middle East J Dig Dis. 2023 Jul;15(3):167-174. doi: 10.34172/mejdd.2023.339. Epub 2023 Jul 30.
3
In-hospital management of inflammatory bowel disease.
炎症性肠病的院内管理。
Curr Opin Gastroenterol. 2023 Jul 1;39(4):274-286. doi: 10.1097/MOG.0000000000000953. Epub 2023 May 26.
4
Predicting inpatient mortality in patients with inflammatory bowel disease: A machine learning approach.预测炎症性肠病患者的住院死亡率:一种机器学习方法。
J Gastroenterol Hepatol. 2023 Feb;38(2):241-250. doi: 10.1111/jgh.16029. Epub 2022 Nov 18.
5
Adalimumab Is Associated With Lower Healthcare Resource and Steroid Use Versus Vedolizumab in Biologic-Naive Crohn's Disease: A Retrospective Claims Database Analysis.在初治生物制剂的克罗恩病中,与维多珠单抗相比,阿达木单抗与更低的医疗资源使用和类固醇使用相关:一项回顾性索赔数据库分析。
Crohns Colitis 360. 2022 Aug 4;4(3):otac029. doi: 10.1093/crocol/otac029. eCollection 2022 Jul.
6
Improved Healthcare Access Reduces Requirements for Surgery in Indigent IBD Patients Using Biologic Therapy: A 'Safety-Net' Hospital Experience.改善医疗服务可减少贫困IBD患者使用生物疗法的手术需求:一家“安全网”医院的经验
Pathophysiology. 2022 Jul 18;29(3):383-393. doi: 10.3390/pathophysiology29030030.
7
Symptoms associated with healthcare resource utilization in the setting of inflammatory bowel disease.炎症性肠病相关的医疗资源利用症状。
Sci Rep. 2022 Jun 22;12(1):10577. doi: 10.1038/s41598-022-14838-y.
8
Role of hospitalization for inflammatory bowel disease in the post-biologic era.生物制剂时代后炎症性肠病住院治疗的作用
World J Clin Cases. 2021 Sep 16;9(26):7632-7642. doi: 10.12998/wjcc.v9.i26.7632.
9
A Simple Emergency Department-Based Score Predicts Complex Hospitalization in Patients with Inflammatory Bowel Disease.基于急诊科的简单评分可预测炎症性肠病患者的复杂住院情况。
Dig Dis Sci. 2022 Feb;67(2):629-638. doi: 10.1007/s10620-021-06877-8. Epub 2021 Feb 19.
10
Biologic therapy is associated with a mild decrease in the rate of hospitalizations in pediatric IBD.生物疗法与儿科 IBD 患者住院率的轻度下降有关。
BMC Pediatr. 2021 Feb 4;21(1):63. doi: 10.1186/s12887-021-02526-1.